- Overview
- Types
- Symptoms
- Causes & Risks
- Tests & Diagnosis
- Treatment
- Living With
- Mobility & Assistive Devices
- Complications
- Caregiving & Support
- Appointment Prep
- View Full Guide
Understanding Multiple Sclerosis (MS)


Understanding Multiple Sclerosis (MS)
Multiple sclerosis is an autoimmune disease that affects the central nervous system. It disrupts the communication between the brain and other parts of the body. Symptoms vary widely but may include fatigue, difficulty walking, and vision problems. Early diagnosis and treatment are crucial for managing the condition effectively.

Types of MS Drugs
MS treatments include disease-modifying therapies (DMTs), corticosteroids for flare-ups, and symptomatic treatments. DMTs aim to reduce the frequency and severity of attacks and slow disease progression. Newer treatments are continually being developed to offer more options for patients.

Common Disease-Modifying Therapies
Common DMTs include interferons (e.g., Avonex, Rebif), glatiramer acetate (Copaxone), and oral therapies like fingolimod (Gilenya) and dimethyl fumarate (Tecfidera). These drugs help manage relapsing forms of MS and come in different forms, from injections to oral pills.

Effectiveness and Side Effects
Each MS drug has varying levels of effectiveness and side effects. Some may be more effective for certain types of MS, while others might have fewer side effects. It's important to discuss these factors with your doctor to find the most suitable treatment for your condition.

Cost and Insurance Considerations
The cost of MS treatments can vary significantly. Insurance coverage and out-of-pocket costs are important factors to consider when choosing a treatment plan. Financial assistance programs may be available to help manage these costs.

Patient Factors in Treatment Choice
Individual factors like age, overall health, lifestyle, and personal preferences play a role in selecting the right MS treatment. It's essential to work closely with your health care team to find a treatment that aligns with your needs and circumstances.

Emerging Research in MS Treatment
Ongoing clinical trials and new drug developments continue to offer hope for better MS treatments. Staying informed about emerging research can help you and your health care provider explore new options as they become available.
PHOTO CREDENTIALS
Slide 1 - Lightspring/Shutterstock
Slide 2 - luchschenF/Shutterstock
Slide 3 - ADragan/Shutterstock
Slide 4 - Prostock-studio/Shutterstock
Slide 5 - Nazarkru/Shutterstock
Slide 6 - PeopleImages.com - Yuri A/Shutterstock
Slide 7 - PanuShot/Shutterstock
SOURCES:
PubMed Health: “Interferon Beta-1a (By injection),” “Interferon Beta-1b.”
Medscape: “Multiple Sclerosis Medication.”
National Multiple Sclerosis Society: “Plasmapheresis,” “Medications,” “Managing Relapses,” “Plegridy,” “Disease Modifying Therapies for MS,” “Copaxone,” “Glatiramer acetate,” “Tecfidera,” “Lemtrada,” “Medications, “Types of MS,” "Interferons," "Copaxone (Glatiramer Acetate)."
UpToDate: “Disease-modifying treatment of relapsing-remitting multiple sclerosis in adults.”
Drugs: “Teriflunomide and Its Mechanism of Action in Multiple Sclerosis.”
Multiple Sclerosis Society (UK): “Natalizumab,” "Beta interferon and glatiramer acetate."
FDA: “FDA approves new drug to treat multiple sclerosis.”
Multiple Sclerosis Coalition: “The Use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence.”
University of Utah College of Pharmacy: “Fingolimod (Gilenya) Drug Review.”
Overcoming Multiple Sclerosis: "Interferons."
Teva Pharmaceutical Industries Ltd.
Biogen Idec.